Ophthalmic myasthenia gravis
Myasthenia gravis (MG) is a chronic autoimmune disease that affects the acetylcholine receptors on the postsynaptic membrane of the neuromuscular junction, leading to impaired nerve-muscle excitation transmission and a tendency to relapse and remission.
-
Site of disease:
Eye -
Infectious :
Not contagious -
Frequent population:
The disease can occur at any age, and relatively... -
Related symptoms:
Abnormal pupil eye movement disorder visual impairment diplopia ptosis -
Concurrent disease:
Related Drugs
Neostigmine Methylsulfate Injection
Indication: Anticholinesterase drugs. Used to antagonize the residual muscle relaxant effect of non-depolarizing muscle relaxants at the end of surgery, and used for myasthenia gravis, postoperative functional intestinal flatulence and urinary retention, etc.
Manufacturer:
Jiangsu Pujin Pharmaceutical Co., Ltd.
Pyridostigmine Bromide Tablets
Indication: Used for myasthenia gravis, functional intestinal flatulence and urinary retention after surgery, etc.
Manufacturer:
SPH Zhongxi Pharmaceutical Co., Ltd.
Pyridostigmine Bromide Tablets
Indication: Used for myasthenia gravis, functional intestinal flatulence and urinary retention after surgery, etc.
Manufacturer:
Shanghai Sine Pharmaceutical Laboratories Co., Ltd.
Related Ingredients